Parenteral Nutrition Market Report 2026
Global Outlook – By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions), By Consumer Type (Children and New-born, Adults), By End-User (Hospitals, Clinics, Homecare, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Parenteral Nutrition Market Overview
• Parenteral Nutrition market size has reached to $7.09 billion in 2025 • Expected to grow to $9.49 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Increasing Birth Rate Fuels Growth In The Parenteral Nutrition Market • Market Trend: Companies Embrace Innovative Multi-Chamber Bag Formulations For Parenteral Nutrition Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Parenteral Nutrition Market?
Parenteral nutrition refers to injecting a certain type of food through a vein as described in medicine (intravenously). Malnutrition correction or prevention is the aim of the therapy. It denotes intravenous feeding (through a vein). Achieving balanced nutritional intake on time can help combat complications and plays a prominent role in a patient’s recovery. The main compositions used in parenteral nutrition include amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other compositions. Amino acids-based parenteral nutrition refers to parenteral nutrition products comprised sourced from amino acids. Amino acids are a standard component of complete parenteral nutrition prescriptions to support cell, organ, skeletal, and respiratory muscle functions, and wound healing. They are used for adults, children, and newborns in hospitals, clinics, home care, and other end-users.
What Is The Parenteral Nutrition Market Size and Share 2026?
The parenteral nutrition market size has grown strongly in recent years. It will grow from $7.09 billion in 2025 to $7.52 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growing incidence of malnutrition, rising hospital admissions, lack of awareness about parenteral nutrition, limited homecare adoption, increasing demand for critical care nutrition.What Is The Parenteral Nutrition Market Growth Forecast?
The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $9.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising geriatric population, expansion of home healthcare services, innovations in nutrient formulations, government support for nutrition programs, integration of digital monitoring in PN therapy. Major trends in the forecast period include advanced nutrient formulations, home parenteral nutrition expansion, personalized nutrition therapy, minimally invasive administration devices, regulatory compliance & safety enhancements.
Global Parenteral Nutrition Market Segmentation
1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions 2) By Consumer Type: Children and New-born, Adults 3) By End-User: Hospitals, Clinics, Homecare, Other End Users Subsegments: 1) By Amino Acids: Essential Amino Acids, Non-Essential Amino Acids, Specialized Amino Acid Solutions 2) By Fats: Lipid Emulsions (Soybean Oil, Olive Oil), Fish Oil-Based Lipid Emulsions, Medium-Chain Triglycerides (MCTs) 3) By Carbohydrates: Dextrose Solutions, Maltodextrin, Fructose 4) By Trace Elements: Zinc, Copper, Selenium, Manganese 5) By Vitamins: Water-Soluble Vitamins (B-complex, Vitamin C), Fat-Soluble Vitamins (A, D, E, K) 6) By Minerals: Electrolytes (Sodium, Potassium, Calcium, Magnesium), Phosphorus 7) By Other Compositions: Antioxidants, Additives, Specialty NutrientsWhat Is The Driver Of The Parenteral Nutrition Market?
The increasing birth rate is expected to propel the growth of the parenteral nutrition market going forward. The birth rate refers to the proportion of live births in the general population per 1,000 people each year. The rise in birth rates and fertility rates is a crucial predictor of increased malnutrition burden among women of childbearing age and new mothers, consequently driving the demand for parenteral nutrition. For instance, in July 2025, according to the Office for National Statistics Census, a UK-based government agency, in 2024, England and Wales recorded 594,677 live births, marking a rise of 3,605 births (0.6%) compared with 591,072 live births in 2023. Therefore, the increasing birth rate will drive the growth of the parenteral nutrition industry.Key Players In The Global Parenteral Nutrition Market
Major companies operating in the parenteral nutrition market are Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Otsuka Pharmaceutical Co Ltd, Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co Ltd, JW Pharmaceuticals, Aculife Healthcare Pvt Ltd, Aspen Pharmacare, Ajinomoto Co Inc, Braun Medical Inc, Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, Sichuan Pharmaceutical Co, Calea UK, Meiji Holdings Co Ltd, United Pharmaceuticals, BioScrip Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Parenteral Nutrition Market Trends and Insights
Major companies operating in the parenteral nutrition market are focusing on developing innovative formulations such as high-calorie amino acid, glucose, electrolyte, fat, and multivitamin injections to improve nutritional support for patients with chronic conditions. High-calorie amino acid, glucose, electrolyte, fat, and multivitamin injections are intravenous formulations providing complete macronutrient and micronutrient support for patients unable to meet nutritional needs orally or enterally. For instance, in November 2024, Otsuka Pharmaceutical Factory, a Japan-based pharmaceutical company, launched KIDPAREN Injection, designed for high-calorie parenteral nutrition in patients with chronic kidney disease. This formulation aims to enhance patient care by providing comprehensive nutrient support, optimizing energy intake, and supporting overall metabolic needs in chronic kidney disease management.What Are Latest Mergers And Acquisitions In The Parenteral Nutrition Market?
In July 2024, Access Infusion Care Inc., a US-based provider of home infusion services, acquired Big Sky I.V. Care, for an undisclosed amount. With this acquisition, Access Infusion aims to expand its geographic footprint, enhance service capabilities, increase patient access to infusion therapies, and strengthen its competitive position in the US home infusion market. Big Sky I.V. Care is a US-based home infusion provider that offers parenteral nutrition.
Regional Insights
North America was the largest region in the parenteral nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Parenteral Nutrition Market?
The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Parenteral Nutrition Market Report 2026?
The parenteral nutrition market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Parenteral Nutrition Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.52 billion |
| Revenue Forecast In 2030 | $9.49 billion |
| Growth Rate | CAGR of 6.1% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Composition, Consumer Type, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Otsuka Pharmaceutical Co Ltd, Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co Ltd, JW Pharmaceuticals, Aculife Healthcare Pvt Ltd, Aspen Pharmacare, Ajinomoto Co Inc, Braun Medical Inc, Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, Sichuan Pharmaceutical Co, Calea UK, Meiji Holdings Co Ltd, United Pharmaceuticals, BioScrip Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |